+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide



Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide



Endocrinology 149(9): 4486-4498



Orally delivered salt stimulates renal salt excretion more effectively than does iv delivered salt. Although the mechanisms that underlie this "postprandial natriuresis" are poorly understood, the peptide uroguanylin (UGn) is thought to be a key mediator. However, the lack of selective assays for UGn gene products has hindered rigorous testing of this hypothesis. Using peptide-specific assays, we now report surprisingly little UGn in rat intestine or plasma. In contrast, prouroguanylin (proUGn), the presumed-inactive precursor of UGn, is plentiful (at least 40 times more abundant than UGn) in both intestine and plasma. The intestine is the likely source of the circulating proUGn because: 1) the proUGn portal to systemic ratio is approximately two under normal conditions, and 2) systemic proUGn levels decrease rapidly after intestinal resection. Together, these data suggest that proUGn itself is actively involved in enterorenal signaling. This is strongly supported by our observation that iv infusion of proUGn at a physiological concentration produces a long-lasting renal natriuresis, whereas previously reported natriuretic effects of UGn have required supraphysiological concentrations. Thus, our data point to proUGn as an endocrine (i.e. circulating) mediator of postprandial natriuresis, and suggest that the propeptide is secreted intact from the intestine into the circulation and processed to an active form at an extravascular site.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 034144068

Download citation: RISBibTeXText

PMID: 18499760

DOI: 10.1210/en.2007-1725


Related references

Comparison of effects of uroguanylin, guanylin, and Escherichia coli heat-stable enterotoxin STa in mouse intestine and kidney: evidence that uroguanylin is an intestinal natriuretic hormone. Journal of Investigative Medicine 45(5): 276-282, 1997

Uroguanylin An intestinal peptide hormone with natriuretic activity. Gastroenterology 106(4 SUPPL ): A808, 1994

Effects of uroguanylin, an intestinal natriuretic peptide, on tubuloglomerular feedback. Hypertension Research 26(7): 577-582, 2003

Guanylin and uroguanylin are GC-C binding intestinal peptide hormones with natriuretic and kaliuretic activity. Journal of Investigative Medicine 43(SUPPL 2): 395A, 1995

Relationship between the actions of atrial natriuretic peptide (ANP), guanylin and uroguanylin on the isolated kidney. Brazilian Journal of Medical and Biological Research 32(8): 1015-1019, 1999

Interaction of atrial natriuretic peptide, urodilatin, guanylin and uroguanylin in the isolated perfused rat kidney. Regulatory Peptides 136(1-3): 14-22, 2006

Expression of natriuretic peptide receptor mRNA and functional response to atrial natriuretic peptide and C-type natriuretic peptide in rainbow trout (Oncorhynchus mykiss) head kidney leucocytes. Fish and Shellfish Immunology 24(4): 373-378, 2008

Natriuretic effects of uroguanylin in the isolated perfuse rat kidney. FASEB Journal 10(3): A14, 1996

Plasma concentration of uroguanylin, a new natriuretic peptide, in nephrotic syndrome. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 402A, Sept, 1998

Uroguanylin A potential natriuretic peptide hormone produced by the intestine. FASEB Journal 8(4-5): A552, 1994

The natriuretic peptide uroguanylin elicits physiologic actions through 2 distinct topoisomers. Hypertension 53(5): 867-876, 2009

Serial changes of uroguanylin, a peptide with natriuretic activity, in PAN-induced nephrotic rats. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 656A, September, 2002

Plasma and urine levels of uroguanylin, a new natriuretic peptide, in nephrotic syndrome. Nephron 81(2): 160-164, 1999

Natriuretic and kaliuretic activities of guanylin and uroguanylin in the isolated perfused rat kidney. American Journal of Physiology 275(2 Pt 2): F191-F197, 1998

Role of uroguanylin, a Peptide with natriuretic activity, in rats with experimental nephrotic syndrome. Journal of the American Society of Nephrology 16(2): 392-397, 2004